1. Agarwal S, Raman R, Paul PG, Rani PK, Uthra S, Gayathree R, McCarty C, Kumaramanickavel G, Sharma T. Sankara nethralaya-diabetic retinopathy epidemiology and molecular genetic study (SN-DREAMS 1): study design and research methodology. Ophthalmic Epidemiol. 2005; 12:143–153.
2. Cong JY, Zhao Y, Xu QY, Zhong CD, Xing QL. Health-related quality of life among Tianjin Chinese patients with type 2 diabetes: a cross-sectional survey. Nurs Health Sci. 2012; 14:528–534.
3. Scollan-Koliopoulos M, Bleich D, Rapp KJ, Wong P, Hofmann CJ, Raghuwanshi M. Health-related quality of life, disease severity, and anticipated trajectory of diabetes. Diabetes Educ. 2013; 39:83–91.
4. Daniele TM, Bruin VM, Oliveira DS, Pompeu CM, Forti AC. Associations among physical activity, comorbidities, depressive symptoms and health-related quality of life in type 2 diabetes. Arq Bras Endocrinol Metabol. 2013; 57:44–50.
5. Egede LE, Hernandez-Tejada MA. Effect of comorbid depression on quality of life in adults with type 2 diabetes. Expert Rev Pharmacoecon Outcomes Res. 2013; 13:83–91.
6. Alzaid A. Diabetes: a tale of two cultures. Br J Diabetes Vasc Dis. 2012; 12:57.
7. Al-Hayek AA, Robert AA, Alzaid AA, Nusair HM, Zbaidi NS, Al-Eithan MH, Sam AE. Association between diabetes self-care, medication adherence, anxiety, depression, and glycemic control in type 2 diabetes. Saudi Med J. 2012; 33:681–683.
8. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27:1047–1053.
9. Camacho F, Anderson RT, Bell RA, Goff DC Jr, Duren-Winfield V, Doss DD, Balkrishnan R. Investigating correlates of health related quality of life in a low-income sample of patients with diabetes. Qual Life Res. 2002; 11:783–796.
10. Genovese S, Tedeschi D. Effects of vildagliptin/metformin therapy on patient-reported outcomes: work productivity, patient satisfaction, and resource utilization. Adv Ther. 2013; 30:152–164.
11. Oguntibeju OO, Odunaiya N, Oladipo B, Truter EJ. Health behaviour and quality of life of patients with type 2 diabetes attending selected hospitals in south western Nigeria. West Indian Med J. 2012; 61:619–626.
12. Myers VH, McVay MA, Brashear MM, Johannsen NM, Swift DL, Kramer K, Harris MN, Johnson WD, Earnest CP, Church TS. Exercise training and quality of life in individuals with type 2 diabetes: a randomized controlled trial. Diabetes Care. 2013; 36:1884–1890.
13. Mikailiukstiene A, Juozulynas A, Narkauskaite L, Zagminas K, Salyga J, Stukas R. Quality of life in relation to social and disease factors in patients with type 2 diabetes in Lithuania. Med Sci Monit. 2013; 19:165–174.
14. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67:361–370.
15. Al Abdulmohsin SA, Coons S, Draugalis JR, Hays RD. Translation of the RAND 36-item health survey 1.0 (aka SF-36) into Arabic. Santa Monica: Rand;1997.
16. Hays RD, Shapiro MF. An overview of generic health-related quality of life measures for HIV research. Qual Life Res. 1992; 1:91–97.
17. Al-Nuaim AR, Mirdad S, Al-Rubeaan K, Al-Mazrou Y, Al-Attas O, Al-Daghari N. Pattern and factors associated with glycemic control of Saudi diabetic patients. Ann Saudi Med. 1998; 18:109–112.
18. Imam K. Management and treatment of diabetes mellitus. Adv Exp Med Biol. 2012; 771:356–380.
19. Unden AL, Elofsson S, Andreasson A, Hillered E, Eriksson I, Brismar K. Gender differences in self-rated health, quality of life, quality of care, and metabolic control in patients with diabetes. Gend Med. 2008; 5:162–180.
20. Song SH. Emerging type 2 diabetes in young adults. Adv Exp Med Biol. 2012; 771:51–61.
21. Hanninen J, Takala J, Keinanen-Kiukaanniemi S. Quality of life in NIDDM patients assessed with the SF-20 questionnaire. Diabetes Res Clin Pract. 1998; 42:17–27.
22. Al-Maskari MY, Al-Shookri AO, Al-Adawi SH, Lin KG. Assessment of quality of life in patients with type 2 diabetes mellitus in Oman. Saudi Med J. 2011; 32:1285–1290.
23. Grant JF, Hicks N, Taylor AW, Chittleborough CR, Phillips PJ. North West Adelaide Health Study Team. Gender-specific epidemiology of diabetes: a representative cross-sectional study. Int J Equity Health. 2009; 8:6.
24. Eljedi A, Mikolajczyk RT, Kraemer A, Laaser U. Health-related quality of life in diabetic patients and controls without diabetes in refugee camps in the Gaza strip: a cross-sectional study. BMC Public Health. 2006; 6:268.
25. Wubben DP, Porterfield D. Health-related quality of life among North Carolina adults with diabetes mellitus. N C Med J. 2005; 66:179–185.
26. Glasgow RE, Ruggiero L, Eakin EG, Dryfoos J, Chobanian L. Quality of life and associated characteristics in a large national sample of adults with diabetes. Diabetes Care. 1997; 20:562–567.
27. Redekop WK, Koopmanschap MA, Stolk RP, Rutten GE, Wolffenbuttel BH, Niessen LW. Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care. 2002; 25:458–463.
28. Bradley C, Todd C, Gorton T, Symonds E, Martin A, Plowright R. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res. 1999; 8:79–91.
29. Holmanova E, Ziakova K. Audit diabetes-dependent quality of life questionnaire: usefulness in diabetes self-management education in the Slovak population. J Clin Nurs. 2009; 18:1276–1286.
30. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med. 1997; 157:1413–1418.
31. American Diabetes Association. Detection and management of lipid disorders in diabetes. Diabetes Care. 1993; 16:828–834.
32. Lloyd A, Sawyer W, Hopkinson P. Impact of long-term complications on quality of life in patients with type 2 diabetes not using insulin. Value Health. 2001; 4:392–400.
33. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998; 352:837–853.
34. UK Prospective Diabetes Study 6. Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors. Diabetes Res. 1990; 13:1–11.
35. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care. 1992; 15:815–819.